FAM60A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.182600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.781400E-01
Normal-vs-Stage2
7.962400E-01
Normal-vs-Stage3
2.353400E-01
Normal-vs-Stage4
4.293200E-01
Stage1-vs-Stage2
4.244400E-01
Stage1-vs-Stage3
6.546600E-01
Stage1-vs-Stage4
1.699200E-01
Stage2-vs-Stage3
3.012800E-01
Stage2-vs-Stage4
4.556000E-01
Stage3-vs-Stage4
1.549600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.483600E-01
Normal-vs-AfricanAmerican
2.339000E-01
Normal-vs-Asian
9.659600E-01
Caucasian-vs-AfricanAmerican
5.720200E-01
Caucasian-vs-Asian
9.829400E-01
AfricanAmerican-vs-Asian
5.744000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.698600E-01
Normal-vs-Female
3.472000E-01
Male-vs-Female
3.466000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.363800E-01
Normal-vs-Age(41-60Yrs)
2.086000E-01
Normal-vs-Age(61-80Yrs)
4.159800E-01
Normal-vs-Age(81-100Yrs)
5.702000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.120400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.038800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.440800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.472020E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.349200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.108400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.869000E-01
Normal-vs-Daily Drinker
9.505400E-01
Normal-vs-Weekly Drinker
5.366300E-02
Normal-vs-Occasional Drinker
3.004400E-02
Normal-vs-Social Drinker
4.957400E-01
Non Drinker-vs-Daily Drinker
6.773000E-01
Non Drinker-vs-Weekly Drinker
1.909370E-01
Non Drinker-vs-Occasional Drinker
1.613570E-02
Non Drinker-vs-Social Drinker
9.735400E-01
Daily Drinker-vs-Weekly Drinker
2.675200E-01
Daily Drinker-vs-Occasional Drinker
1.564770E-01
Daily Drinker-vs-Social Drinker
6.883000E-01
Weekly Drinker-vs-Occasional Drinker
5.723700E-03
Weekly Drinker-vs-Social Drinker
3.161200E-01
Occasional Drinker-vs-Social Drinker
3.121800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.038840E-01
Normal-vs-Grade 2
2.230300E-02
Normal-vs-Grade 3
4.728200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.450800E-01
Grade 1-vs-Grade 3
4.904200E-02
Grade 1-vs-Grade 4
1.038840E-01
Grade 2-vs-Grade 3
5.089900E-02
Grade 2-vs-Grade 4
2.230300E-02
Grade 3-vs-Grade 4
4.728200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.007500E-02
Normal-vs-NonDiabetic
7.659200E-01
Diabetic-vs-NonDiabetic
7.978100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.546200E-01
Normal-vs-NoPancreatitis
8.016400E-01
Pancreatitis-vs-NoPancreatitis
7.050800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.434200E-01
Normal-vs-N1
8.169400E-01
N0-vs-N1
6.310800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.335000E-01
Normal-vs-TP53-NonMutant
8.949400E-01
TP53-Mutant-vs-TP53-NonMutant
1.244330E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
